MX337488B - Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes. - Google Patents
Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.Info
- Publication number
- MX337488B MX337488B MX2011000709A MX2011000709A MX337488B MX 337488 B MX337488 B MX 337488B MX 2011000709 A MX2011000709 A MX 2011000709A MX 2011000709 A MX2011000709 A MX 2011000709A MX 337488 B MX337488 B MX 337488B
- Authority
- MX
- Mexico
- Prior art keywords
- dosage forms
- solid dosage
- preparation
- sodium ibuprofen
- high content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Los gránulos de dihidrato de ibuprofeno sódico racémico formados a partir de componentes especificados en la presente, tienen propiedades muy deseables y se pueden usar efectivamente en el equipo de tableteado de prensa rotatoria convencional sin dificultades operacionales frecuentemente encontradas en la práctica actual. Su preparación por un proceso de granulación húmeda, las composiciones de gránulos húmedos, formulaciones adaptadas para la preparación de formas de dosificación sólidas utilizando una prensa rotatoria, formas farmacéuticas sólidas, y métodos para preparar formas farmacéuticas sólidas en una prensa rotatoria también se describen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8244508P | 2008-07-21 | 2008-07-21 | |
PCT/US2009/050405 WO2010011522A1 (en) | 2008-07-21 | 2009-07-13 | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011000709A MX2011000709A (es) | 2011-02-24 |
MX337488B true MX337488B (es) | 2016-03-08 |
Family
ID=41259057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011000709A MX337488B (es) | 2008-07-21 | 2009-07-13 | Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes. |
Country Status (10)
Country | Link |
---|---|
US (2) | US9629806B2 (es) |
EP (1) | EP2309988B1 (es) |
JP (1) | JP5553830B2 (es) |
CN (1) | CN102099017A (es) |
AR (1) | AR072826A1 (es) |
BR (1) | BRPI0916344A2 (es) |
CA (1) | CA2730005C (es) |
CL (1) | CL2009001613A1 (es) |
MX (1) | MX337488B (es) |
WO (1) | WO2010011522A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0916344A2 (pt) | 2008-07-21 | 2020-07-21 | Albemarle Corporation | grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes |
US9629809B2 (en) | 2008-07-21 | 2017-04-25 | Si Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
BR112015013945A8 (pt) * | 2012-12-14 | 2019-10-08 | Si Group Inc | grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes |
KR101890649B1 (ko) * | 2013-07-30 | 2018-09-28 | 라이온 가부시키가이샤 | 정제 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US290168A (en) * | 1883-12-11 | Commode attachment for wash-stands | ||
NL6607516A (es) | 1966-05-31 | 1967-12-01 | ||
DE3437599C2 (de) | 1984-10-13 | 1987-04-16 | Dolorgiet GmbH & Co KG, 5205 St Augustin | Ibuprofen enthaltende Weichgelatinekapseln |
US4564697A (en) | 1984-11-29 | 1986-01-14 | Ethyl Corporation | Halogenated polyol-ester neutralization agent |
US5071643A (en) | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
US4806359A (en) | 1987-04-22 | 1989-02-21 | Mcneilab, Inc. | Iburprofen sustained release matrix and process |
US4861797A (en) | 1987-10-15 | 1989-08-29 | Oratech Pharmaceutical Development Corporation | Liquid ibuprofen compositions and methods of making them |
US4859704A (en) | 1987-10-15 | 1989-08-22 | Oratech Pharmaceutical Development Corporation | Water soluble ibuprofen compositions and methods of making them |
DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
US5104648A (en) | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
JP3121080B2 (ja) | 1991-12-19 | 2000-12-25 | アール・ピー・シーラー コーポレイション | カプセル封入用溶液 |
ATE180668T1 (de) | 1992-12-01 | 1999-06-15 | Spirig Ag | S(+)-ibuprofen enthaltende arzneimittel |
US5376688A (en) | 1992-12-18 | 1994-12-27 | R. P. Scherer Corporation | Enhanced solubility pharmaceutical solutions |
GB9603699D0 (en) | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
IT1293764B1 (it) | 1997-07-23 | 1999-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua |
DE19733505A1 (de) | 1997-08-01 | 1999-02-04 | Knoll Ag | Schnell wirksames Analgeticum |
US6194568B1 (en) * | 1998-07-13 | 2001-02-27 | Merck & Co., Inc. | Process for synthesizing carbapenem intermediates |
IT1301966B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
US6392502B2 (en) * | 1998-12-17 | 2002-05-21 | The Whitaker Corporation | Balun assembly with reliable coaxial connection |
US6340473B1 (en) | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
US6387400B1 (en) | 2000-08-29 | 2002-05-14 | R.P. Scherer Technologies, Inc. | Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
AU2002220248A1 (en) | 2000-11-06 | 2002-05-15 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
DE20204655U1 (de) * | 2002-03-21 | 2002-06-13 | stryker Trauma GmbH, 24232 Schönkirchen | Verriegelungsnagel und Zielgerät |
CH693586A8 (de) * | 2002-10-14 | 2003-12-15 | Roche Consumer Health Ag | Darreichungsform von Ibuprofen-Natrium. |
US20080020042A1 (en) | 2003-10-14 | 2008-01-24 | Peter Gruber | Dosage form of sodium ibuprofen |
US20050137262A1 (en) | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
JP2005324170A (ja) * | 2004-05-17 | 2005-11-24 | Kissei Pharmaceut Co Ltd | 振動篩装置及びその運転方法 |
JP4753567B2 (ja) | 2004-11-19 | 2011-08-24 | 旭化成ケミカルズ株式会社 | 付着性の高い薬物を含有する錠剤の製造方法 |
DE102005009241A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
AU2006226293B2 (en) * | 2005-03-22 | 2011-04-07 | Losan Pharma Gmbh | Solubilized ibuprofen |
EP1800667A1 (en) * | 2005-12-23 | 2007-06-27 | Losan Pharma GmbH | Rapidly solubilizing ibuprofen granulate |
CN101257800B (zh) * | 2005-07-18 | 2012-07-18 | 好利用医疗公司 | 包含法莫替丁和布洛芬的药物 |
BRPI0916344A2 (pt) | 2008-07-21 | 2020-07-21 | Albemarle Corporation | grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes |
MX2020011961A (es) | 2010-03-24 | 2022-04-19 | Jazz Pharmaceuticals Inc | Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas. |
-
2009
- 2009-07-13 BR BRPI0916344-1A patent/BRPI0916344A2/pt not_active Application Discontinuation
- 2009-07-13 US US13/054,369 patent/US9629806B2/en not_active Expired - Fee Related
- 2009-07-13 EP EP09790340.5A patent/EP2309988B1/en not_active Not-in-force
- 2009-07-13 WO PCT/US2009/050405 patent/WO2010011522A1/en active Application Filing
- 2009-07-13 CN CN2009801283043A patent/CN102099017A/zh active Pending
- 2009-07-13 CA CA2730005A patent/CA2730005C/en not_active Expired - Fee Related
- 2009-07-13 MX MX2011000709A patent/MX337488B/es active IP Right Grant
- 2009-07-13 JP JP2011520090A patent/JP5553830B2/ja not_active Expired - Fee Related
- 2009-07-20 CL CL2009001613A patent/CL2009001613A1/es unknown
- 2009-07-20 AR ARP090102755A patent/AR072826A1/es not_active Application Discontinuation
-
2017
- 2017-03-15 US US15/459,862 patent/US10391072B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5553830B2 (ja) | 2014-07-16 |
AR072826A1 (es) | 2010-09-22 |
US9629806B2 (en) | 2017-04-25 |
CL2009001613A1 (es) | 2010-07-19 |
CA2730005A1 (en) | 2010-01-28 |
WO2010011522A1 (en) | 2010-01-28 |
CN102099017A (zh) | 2011-06-15 |
EP2309988A1 (en) | 2011-04-20 |
US20110182984A1 (en) | 2011-07-28 |
EP2309988B1 (en) | 2015-11-25 |
CA2730005C (en) | 2017-06-13 |
JP2011528712A (ja) | 2011-11-24 |
US20170181992A1 (en) | 2017-06-29 |
BRPI0916344A2 (pt) | 2020-07-21 |
MX2011000709A (es) | 2011-02-24 |
US10391072B2 (en) | 2019-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090554L (no) | Farmasoytiske preparater av memantin | |
NO20091501L (no) | Farmasoytiske sammensetninger | |
WO2014101986A8 (en) | Dry granulation process for producing tablet compositions of metformin and compositions thereof | |
WO2009043844A3 (en) | Orodispersible tablets | |
NZ727015A (en) | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
EP2210591A3 (en) | Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose | |
WO2007005633A8 (en) | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate | |
EA201300053A1 (ru) | Фосфатсвязывающий препарат для удобного приема | |
RS54241B1 (en) | INHALATION COMPONENT CONTAINING ACLIDINIUM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
UA99136C2 (ru) | Улучшенная фармацевтическая композиция, содержащая антагонист кальциевых каналов - лерканидипин, способ ее получения | |
MX2012006851A (es) | Granulos para preparaciones farmceuticas, metodos y aparatos para su produccion. | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
MX337488B (es) | Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes. | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
MX2007010400A (es) | Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo. | |
ZA201003380B (en) | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof | |
UA95274C2 (ru) | Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления | |
WO2011056785A3 (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
WO2009084036A3 (en) | Composition for treatment of viral infections | |
AR066000A1 (es) | Procedimiento para preparar comprimidos de dihidrocloruro de pramipexol | |
EA201990129A1 (ru) | Таблетированный состав с улучшенным профилем растворения для лечения болезни паркинсона | |
UA105285C2 (uk) | Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання | |
MX359887B (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
RU2015129714A (ru) | Композиция в форме таблеток, содержащая гидрохлорид цинакалцета | |
WO2011063775A3 (en) | Pectin complexes of sartans and pharmaceutical compositions based thereon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: SI GROUP, INC.* |
|
FG | Grant or registration |